Skip to main content
SpringerLink
Log in

Stereoselective Hepatic Disposition of Model Diastereomeric Acyl Glucuronides

  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Numerous studies have previously been conducted with the impulse-response isolated perfused rat liver (IR-IPRL) to establish the role of both physiological and physicochemical factors in determining solutes' pattern of hepatic disposition, however the impact of optical isomerism on hepatic disposition has hardly been studied using this methodology. In this study, the IR-IPRL was used to assess the extent of stereoselectivity exhibited by the kinetic processes involved in the hepatic disposition of the diastereomeric acyl glucuronides of (R)- and (S)-2-phenylpropionic acid (i.e. (R)- and (S)-PPAG). Moment and model-dependent (distributed model and axial dispersion model) analyses were conducted of the hepatic outflow profiles generated upon bolus administration of (R)-14C-PPAG, or (S)-14C-PPAG and 3H-Sucrose (used as a marker of the hepatic vascular space) into the portal inflow of isolated perfused livers of male Sprague–Dawley rats (n=4). Significant differences between (R)- and (S)-PPAG were apparent in the pharmacokinetic parameters defining the total hepatic disposition of the two diastereomers, the most marked being the hepatic availabilities, where the value for (S)-PPAG (0.721±0.059) was significantly lower than that of (R)-PPAG (0.909±0.042). The distributed and axial dispersion model analyses suggested that the more extensive hepatic extraction of (S)-PPAG was (at least in part) due to the higher sinusoidal membrane permeability-surface area product (PSupt) of that diastereomer, and this has been considered in light of the emerging evidence regarding the role of hepatocellular membrane transport mechanisms. Furthermore, given the potential immunogenicity of acyl glucuronides (through covalent binding to plasma and intracellular proteins), the results of this study suggest that diastereomeric glucuronides may exhibit differing toxicity due to differences in their access to intracellular proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. C.¡H.¡ Chou,¡A.¡J.¡ McLachlan,and¡M.¡ Rowland.¡Membrane-permeability¡and¡lipophilicity¡in¡the¡isolated-perfused¡rat-liver—5-ethyl¡barbituric-acid¡and¡other¡compounds.¡J.¡Pharmacol.¡Exp.¡Ther.¡275:933-940¡(1995).

    Google Scholar 

  2. C.¡H.¡ Chou,¡A.¡M.¡ Evans,¡G.¡ Fornasini,¡and¡M.¡ Rowland.¡Relationship¡between¡lipophilicity¡and¡hepatic¡dispersion¡and¡distribution¡for¡a¡homologous¡series¡of¡barbiturates¡in¡the¡isolated¡perfused¡insitu¡rat¡liver.¡Drug¡Metab.¡Dispos.¡21:933-938¡(1993).

    Google Scholar 

  3. G.¡D.¡ Mellick¡and¡M.¡S.¡ Roberts.¡Structure-hepatic¡disposition¡relationships¡for¡phenolic¡compounds.¡Toxicol.¡Appl.¡Pharmacol.¡158:50-60¡(1999).

    Google Scholar 

  4. D.¡Y.¡ Hung,¡G.¡D.¡ Mellick,¡Y.¡G.¡ Anissimov,¡M.¡ Weiss,¡and¡M.¡S.¡ Roberts.¡Hepatic¡structure-pharmacokinetic¡relationships:¡The¡hepatic¡disposition¡and¡metabolite¡kinetics¡of¡a¡homologous¡series¡of¡O-acyl¡derivatives¡of¡salicylic¡acid.¡Br.¡J.¡Pharmacol.¡124:1475-1483¡(1998).

    Google Scholar 

  5. D.¡Y.¡ Hung,¡G.¡D.¡ Mellick,¡Y.¡G.¡ Anissimov,¡M.¡ Weiss,¡and¡M.¡S.¡ Roberts.¡Hepatic¡disposition¡and¡metabolite¡kinetics¡of¡a¡homologous¡series¡of¡diflunisal¡esters.¡J.¡Pharmaceut.¡Sci.¡87:943-951¡(1998).

    Google Scholar 

  6. D.¡M.¡ Shackleford,¡P.¡J.¡ Hayball,¡G.¡D.¡ Reynolds,¡D.¡P.¡G.¡ Hamon,¡A.¡M.¡ Evans,¡R.¡W.¡ Milne,¡and¡R.¡L.¡ Nation.¡A¡small-scale¡synthesis¡and¡enantiomeric¡resolution¡of¡(RS)-[1-C-14]-2-phenylpropionic¡acid¡and¡biosynthesis¡of¡its¡diastereomeric¡acyl¡glucuronides.¡J.¡Labelled¡Comp.¡Rad.¡44:225-234¡(2001).

    Google Scholar 

  7. A.¡M.¡ Evans¡and¡K.¡ Shanahan.¡The¡disposition¡of¡morphine¡and¡Its¡metabolites¡in¡the¡in-situ¡rat¡isolated¡perfused¡liver.¡J.¡Pharm.¡Pharmacol.¡47:333-339¡(1995).

    Google Scholar 

  8. Y.¡ Nakamura¡and¡T.¡ Yamaguchi.¡Stereoselective¡metabolism¡of¡2-phenylpropionic¡acid¡in¡rat¡.1.¡Invitro¡studies¡on¡the¡stereoselective¡isomerization¡and¡glucuronidation¡of¡2¡phenylpropionic¡acid.¡Drug¡Metabol.¡Dispos.¡15:529-534¡(1987).

    Google Scholar 

  9. K.¡ Akira,¡H.¡ Hasegawa,¡Y.¡ Shinohara,¡M.¡ Imachi,¡and¡T.¡ Hashimoto.¡Stereoselective¡internal¡acyl¡migration¡of¡1¡beta-O-acyl¡glucuronides¡of¡enantiomeric¡2-phenylpropionic¡acids.¡Biol.¡Pharmaceut.¡Bull.¡23:506-510¡(2000).

    Google Scholar 

  10. C.¡A.¡ Goresky,¡G.¡G.¡ Bach,¡and¡B.¡E.¡ Nadeau.¡On¡the¡uptake¡of¡materials¡by¡the¡intact¡liver:¡The¡concentrative¡transport¡of¡Rubidium-86.¡J.¡Clin.¡Invest.¡52:975-990¡(1973).

    Google Scholar 

  11. M.¡S.¡ Roberts¡and¡M.¡ Rowland.¡A¡dispersion¡model¡of¡hepatic¡elimination:¡1.¡Formulation¡of¡the¡model¡and¡bolus¡considerations.¡J.¡Pharmacokinet.¡Biopharm.¡14:227-260¡(1986).

    Google Scholar 

  12. A.¡M.¡ Evans,¡Z.¡ Hussein,¡and¡M.¡ Rowland.¡A¡2-compartment¡dispersion¡model¡describes¡the¡hepatic¡outflow¡profile¡of¡diclofenac¡in¡the¡presence¡of¡Its¡binding-protein.¡J.¡Pharm.¡Pharmacol.¡43:709-714¡(1991).

    Google Scholar 

  13. Y.¡ Yano,¡K.¡ Yamaoka,¡and¡H.¡ Tanaka.¡A¡nonlinear¡least-squares¡program,¡Multi(Filt),¡based¡on¡fast¡inverse¡laplace¡transform¡for¡microcomputers.¡Chem.¡Pharmaceut.¡Bull.¡37:1035-1038¡(1989).

    Google Scholar 

  14. Y.¡ Giroud,¡P.-ACarrupt,¡A.¡ Pagliara,¡B.¡ Testa,¡and¡R.¡G.¡ Dickinson.¡Intrinsic¡and¡intramolecular¡lipophilicity¡effects¡in¡O-glucuronides.¡Helv.¡Chim.¡Acta¡81:330-341¡(1998).

    Google Scholar 

  15. C.¡A.¡ Goresky,¡G.¡G.¡ Bach,¡A.¡ Simard,¡A.¡J.¡ Schwab,¡and¡A.¡ Bracht.¡Uptake¡of¡lactate¡by¡the¡liver:¡Effect¡of¡red¡blood¡cell¡carriage.¡Am.¡J.¡Physiol.—Gastr.¡Liver¡Physiol.¡278:G775-G788¡(2000).

    Google Scholar 

  16. W.¡P.¡ Geng,¡A.¡J.¡ Schwab,¡C.¡A.¡ Goresky,¡and¡K.¡S.¡ Pang.¡Carrier-mediated¡uptake¡and¡excretion¡of¡bromosulfophthalein–glutathione¡in¡perfused¡rat¡liver—a¡multiple¡indicator¡dilution¡study.¡Hepatology¡22:1188-1207¡(1995).

    Google Scholar 

  17. C.¡A.¡ Goresky,¡K.¡S.¡ Pang,¡A.¡J.¡ Schwab,¡F.¡ Barker,¡W.¡F.¡ Cherry,¡and¡G.¡G.¡ Bach.¡Uptake¡of¡a¡protein-bound¡polar¡compound,¡acetaminophen¡sulfate,¡by¡perfused-rat-liver.¡Hepatology¡16:173-190¡(1992).

    Google Scholar 

  18. Z.¡ Hussein,¡A.¡J.¡ McLachlan,¡and¡M.¡ Rowland.¡Distribution¡kinetics¡of¡salicylic¡acid¡in¡the¡isolated¡perfused¡rat¡liver¡assessed¡using¡moment¡analysis¡and¡the¡two-compartment¡axial¡dispersion¡model.¡Pharmaceut.¡Res.¡11:1337-1345¡(1994).

    Google Scholar 

  19. S.¡ Miyauchi,¡Y.¡ Sugiyama,¡T.¡ Iga,¡and¡M.¡ Hanano.¡Membrane-limited¡hepatic¡transport¡of¡the¡conjugative¡metabolites¡of¡4-methylumbelliferone¡in¡rats.¡J.¡Pharmaceut.¡Sci.¡77:688-692¡(1988).

    Google Scholar 

  20. S.¡ Miyauchi,¡Y.¡ Sugiyama,¡T.¡ Iga,¡and¡M.¡ Hanano.¡The¡conjugative¡metabolism¡of¡4-methylumbelliferone¡and¡deconjugation¡to¡the¡parent¡drug¡examined¡by¡isolated¡perfused¡liver¡and¡in¡vivo¡liver¡homogenate¡of¡rats.¡Chem.¡Pharmaceut.¡Bull.¡37:475-480¡(1989).

    Google Scholar 

  21. S.¡ Ratna,¡M.¡ Chiba,¡L.¡ Bandyopadhyay,¡and¡K.¡S.¡ Pang.¡Futile¡cycling¡between¡4-methylumbelliferone¡and¡its¡conjugates¡in¡perfused-rat-liver.¡Hepatology¡17:838-853¡(1993).

    Google Scholar 

  22. H.¡ Suzuki¡and¡Y.¡ Sugiyama.¡Transport¡of¡drugs¡across¡the¡hepatic¡sinusoidal¡membrane:¡Sinusoidal¡drug¡influx¡and¡efflux¡in¡the¡liver.¡Semin.¡Liver¡Dis.¡20:251-263¡(2000).

    Google Scholar 

  23. I.¡ Tamai,¡H.¡ Takanaga,¡H.¡ Maeda,¡Y.¡ Sai,¡T.¡ Ogihara,¡H.¡ Higashida,¡and¡A.¡ Tsuji.¡Participation¡of¡a¡proton-cotransporter,¡MCT1,¡in¡the¡intestinal¡transport¡of¡monocarboxylic¡acids.¡Biochem.¡Biophys.¡Res.¡Commun..¡214:482-489¡(1995).

    Google Scholar 

  24. T.¡ Ogihara,¡I.¡ Tamai,¡and¡A.¡ Tsuji.¡Structural¡requirements¡of¡substrates¡for¡stereoselective¡monocarboxylate¡transport¡in¡caco-cells.¡Pharm.¡Pharmacol.¡Commun.¡6:161-165¡(2000).

    Google Scholar 

  25. M.¡S.¡ Roberts,¡S.¡ Fraser,¡A.¡ Wagner,¡and¡L.¡ McLeod.¡Residence¡time¡distributions¡of¡solutes¡in¡the¡perfused¡rat¡liver¡using¡a¡dispersion¡model¡of¡hepatic¡elimination.¡Part¡2.¡Effect¡of¡pharmacological¡agents,¡retrograde¡perfusions,¡and¡enzyme¡inhibition¡on¡Evans¡blue,¡sucrose,¡water,¡and¡taurocholate.¡J.¡Pharmacokinet.¡Biop.¡18:235-258¡(1990).

    Google Scholar 

  26. K.¡S.¡ Pang,¡W.¡F.¡ Lee,¡W.¡F.¡ Cherry,¡V.¡ Yuen,¡and¡C.¡A.¡ Goresky¡et¡al.¡Effects¡of¡perfusate¡flow¡rate¡on¡measured¡blood¡volume,¡disse¡space,¡intracellular¡water¡space,¡and¡drug¡extraction¡in¡the¡perfused¡rat¡liver¡preparation:¡Characterization¡by¡the¡multiple¡indicator¡dilution¡technique.¡J.¡Pharmacokinet.¡Biop.¡16:595-632¡(1988).

    Google Scholar 

  27. S.¡ Iwakawa,¡H.¡ Spahn,¡L.¡Z.¡ Benet,¡and¡E.¡T.¡ Lin.¡Stereoselective¡binding¡of¡the¡glucuronide¡conjugates¡of¡carprofen¡enantiomers¡to¡human¡serum¡albumin.¡Biochem.¡Pharmacol.¡39:949-953¡(1990).

    Google Scholar 

  28. P.¡J.¡ Hayball,¡R.¡L.¡ Nation,¡and¡F.¡ Bochner.¡Stereoselective¡interactions¡of¡ketoprofen¡glucuronides¡with¡human¡plasma¡protein¡and¡serum¡albumin.¡Biochem.¡Pharmacol.¡44:291-299¡(1992).

    Google Scholar 

  29. A.¡ Bischer,¡P.¡ Zia-Amirhosseini,¡M.¡ Iwaki,¡A.¡F.¡ McDonagh,¡and¡L.¡Z.¡ Benet.¡Stereoselective¡binding¡properties¡of¡naproxen¡glucuronide¡diastereomers¡to¡protein.¡J.¡Pharmackinet.¡Biop.¡23:379-395¡(1995).

    Google Scholar 

  30. M.¡H.¡ Devries,¡G.¡J.¡ Mulder,¡G.¡M.¡M.¡ Groothuis,¡and¡D.¡K.¡F.¡ Meijer.¡Secretion¡of¡harmol¡sulfate¡from¡liver¡Into¡blood—evidence¡for¡a¡carrier-mediated¡mechanism.¡Hepatology¡4:771(1984).

    Google Scholar 

  31. L.¡ Sabordo,¡B.¡C.¡ Sallustio,¡A.¡M.¡ Evans,¡and¡R.¡L.¡ Nation.¡Hepatic¡disposition¡of¡the¡acyl¡glucuronide1-O-gemfibrozil-beta-D-glucuronide:¡Effects¡of¡dibromosulfophthalein¡on¡membrane¡transport¡and¡aglycone¡formation¡[In¡Process¡Citation].¡J.¡Pharmacol.¡Exp.¡Ther.¡288:414-420¡(1999).

    Google Scholar 

  32. L.¡ Sabordo,¡B.¡C.¡ Sallustio,¡A.¡M.¡ Evans,¡and¡R.¡L.¡ Nation.¡Hepatic¡disposition¡of¡the¡acyl¡glucuronide¡1-O-gemfibrozil-β-D-glucuronide:¡Effects¡of¡Clofibric¡Acid,¡acetaminophen,¡and¡acetaminophen¡glucuronide.¡J.¡Pharm.¡Exp.¡Ther.¡295:44-50¡(2000).

    Google Scholar 

  33. H.¡ Sasabe,¡Y.¡ Kato,¡A.¡ Tsuji,¡and¡Y.¡ Sugiyama.¡Stereoselective¡hepatobiliary¡transport¡of¡the¡quinolone¡antibiotic¡grepafloxacin¡and¡its¡glucuronide¡in¡the¡rat.¡J.¡Pharm.¡Exp.¡Ther.¡284:661-668¡(1998).

    Google Scholar 

  34. M.¡ Murata,¡I.¡ Tamai,¡Y.¡ Sai,¡O.¡ Nagata,¡H.¡ Kato,¡Y.¡ Sugiyama,¡and¡A.¡ Tsuji.¡Hepatobiliary¡transport¡kinetics¡of¡HSR-903,¡a¡new¡quinolone¡antibacterial¡agent.¡Drug¡Metabol.¡Dispos.¡26:1113-1119¡(1998).

    Google Scholar 

  35. H.¡ Suzuki.¡Analysis¡of¡xenobiotic¡detoxification¡system¡mediated¡by¡efflux¡transporters.¡Yakugaku¡Zasshi—J.¡Pharmaceut.¡Soc.¡Jpn.¡119:822-834¡(1999).

    Google Scholar 

  36. K.¡ Ogawa,¡H.¡ Suzuki,¡T.¡ Hirohashi,¡T.¡ Ishikawa,¡P.¡J.¡ Meier,¡K.¡ Hirose,¡T.¡ Akizawa,¡M.¡ Yoshioka,¡and¡Y.¡ Sugiyama.¡Characterization¡of¡inducible¡nature¡of¡MRP3¡in¡rat¡liver.¡Am.¡J.¡Physiol.¡Gastr.¡Liver¡Physiol..¡278:G438-G446¡(2000).

    Google Scholar 

  37. P.¡J.¡ Hayball.¡Formation¡and¡reactivity¡of¡acyl¡glucuronides—the¡influence¡of¡chirality.¡Chirality 7:1-9¡(1995).

    Google Scholar 

  38. Y.¡ Yano,¡K.¡ Yamaoka,¡Y.¡ Aoyama,¡and¡H.¡ Tanaka.¡Two-compartment¡dispersion¡model¡for¡analysis¡of¡organ¡perfusion¡system¡of¡drugs¡by¡fast¡inverse¡laplace¡transform¡(FILT).¡J.¡Pharmacokinet.¡Biop.¡12:179-202¡(1989).

    Google Scholar 

  39. M.¡S.¡ Roberts,¡J.¡D.¡ Donaldson,¡and¡M.¡ Rowland.¡Models¡of¡hepatic¡elimination:¡Comparison¡of¡stochastic¡models¡to¡describe¡residence¡time¡distributions¡and¡to¡predict¡the¡influence¡of¡drug¡distribution,¡enzyme¡heterogeneity,¡and¡systemic¡recycling¡on¡hepatic¡elimination.¡J.¡Pharmacokinet.¡Biop.¡16:41-83¡(1988).

    Google Scholar 

Download references

Author information

Author notes

  1. David M. Shackleford

    Present address: Department of Pharmaceutics, Victorian College of Pharmacy, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria, 3052, Australia

  2. Roger L. Nation

    Present address: Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria, 3052, Australia

Authors and Affiliations

  1. Centre for Pharmaceutical Research, School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Frome Road, Adelaide, South Australia, Australia

    David M. Shackleford, Roger L. Nation, R.W. Milne, P.J. Hayball & Allan M. Evans

Authors
  1. David M. Shackleford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger L. Nation
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R.W. Milne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P.J. Hayball
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Allan M. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allan M. Evans.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shackleford, D.M., Nation, R.L., Milne, R. et al. Stereoselective Hepatic Disposition of Model Diastereomeric Acyl Glucuronides. J Pharmacokinet Pharmacodyn 31, 1–27 (2004). https://doi.org/10.1023/B:JOPA.0000029486.60317.25

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:JOPA.0000029486.60317.25

Search

Navigation